Varex Imaging (NASDAQ:VREX) Updates Q3 Earnings Guidance

→ Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad)

Varex Imaging (NASDAQ:VREX - Get Free Report) updated its third quarter earnings guidance on Thursday. The company provided EPS guidance of $0.05 to $0.25 for the period, compared to the consensus EPS estimate of $0.30. The company issued revenue guidance of $200 million to $220 million, compared to the consensus revenue estimate of $224.50 million.

Wall Street Analysts Forecast Growth

Separately, TheStreet cut Varex Imaging from a b- rating to a c rating in a research note on Tuesday, February 6th.

Read Our Latest Stock Analysis on VREX

Varex Imaging Stock Performance

Shares of VREX traded down $0.15 during mid-day trading on Thursday, reaching $16.43. The company's stock had a trading volume of 526,654 shares, compared to its average volume of 319,548. Varex Imaging has a 1-year low of $16.00 and a 1-year high of $23.90. The stock has a market cap of $667.06 million, a P/E ratio of 17.11, a PEG ratio of 2.34 and a beta of 0.72. The business has a 50-day simple moving average of $17.35 and a two-hundred day simple moving average of $18.51. The company has a current ratio of 4.30, a quick ratio of 2.37 and a debt-to-equity ratio of 0.76.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its earnings results on Tuesday, February 6th. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.05). Varex Imaging had a return on equity of 9.21% and a net margin of 5.08%. The firm had revenue of $190.00 million for the quarter, compared to the consensus estimate of $187.97 million. During the same quarter last year, the business posted $0.08 EPS. Varex Imaging's revenue for the quarter was down 7.6% on a year-over-year basis. As a group, equities research analysts anticipate that Varex Imaging will post 0.99 earnings per share for the current fiscal year.


About Varex Imaging

(Get Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Read More

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)

Should you invest $1,000 in Varex Imaging right now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: